Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

  1. OncologyPRO
  2. Meeting resources
  3. ESMO World Congress on Gastrointestinal Cancer 2021

Session VI: Rare GI Tumors: NETs, GISTs, and Anal cancer

SO-12: Updated safety, efficacy and PK results from an open-label, multicenter, phase I/II study of avapritinib in Chinese patients with unresectable or metastatic gastrointestinal stromal tumors (GIST)

Date

01 Jul 2021

Session

Session VI: Rare GI Tumors: NETs, GISTs, and Anal cancer

Topics

Tumour Site

GIST

Presenters

Jian Li, China (People's Republic)

Resources

Login to access the resources on OncologyPRO.

Login

Resources from the same session

Q&A

Presenter: George Demetri, United States; Karin Haustermans, Belgium; Juan Manuel O'Connor, Argentina; Harpreet Wasan, United Kingdom; Cathy Eng, United States

Session: Session VI: Rare GI Tumors: NETs, GISTs, and Anal cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.